Reviews in
Neuro-Oncology


Volume 21 Number 3
March 2019


Home > Disciplines > Publications > Reviews on Neuro-Oncology > Volume 21, Year 2019 > Number 3, March


CONTENTS


CENTRAL NERVOUS SYSTEM TUMORS

GLIOMAS
BRAIN STEM GLIOMAS
DIFFUSE INTRINSIC PONTINE GLIOMAS
HIGH-GRADE GLIOMAS

DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS
GLIOBLASTOMA
OLIGODENDROGLIOMAS

OTHER ASTROCYTIC TUMORS
PILOCYTIC ASTROCYTOMA

OTHER GLIOMAS
CHORDOID GLIOMA OF THE THIRD VENTRICLE

EMBRYONAL TUMORS
MEDULLOBLASTOMA





CENTRAL NERVOUS SYSTEM TUMORS

.

Díez Valle R, Hadjipanayis CG, Stummer W.
Established and emerging uses of 5-ALA in the brain: an overview.
J Neurooncol. 2019 Feb;141(3):487-494. doi: 10.1007/s11060-018-03087-7. Epub 2019 Jan 3.
Source | Full text | Similar articles



.

Mirian C, Møller Pedersen M, Sabers A, Mathiesen T.
Antiepileptic drugs as prophylaxis for de novo brain tumour-related epilepsy after craniotomy: a systematic review and meta-analysis of harm and benefits.
J Neurol Neurosurg Psychiatry. 2019 Jan 23. pii: jnnp-2018-319609. doi: 10.1136/jnnp-2018-319609. [Epub ahead of print]
Source | Full text | Similar articles



.

Mitrasinovic S, Zhang M, Appelboom G, Sussman E, Moore JM, Hancock SL, Adler JR, Kondziolka D, Steinberg GK, Chang SD.
Milestones in stereotactic radiosurgery for the central nervous system.
J Clin Neurosci. 2019 Jan;59:12-19. doi: 10.1016/j.jocn.2018.09.029. Epub 2018 Oct 26.
Source | Full text | Similar articles



GLIOMAS

.

Ma Q, Long W, Xing C, Chu J, Luo M, Wang HY, Liu Q, Wang RF.
Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma.
Front Immunol. 2018 Dec 21;9:2924. doi: 10.3389/fimmu.2018.02924. eCollection 2018.
Source | Full text | Similar articles



.

Maitra S, Bhattacharya D, Das S, Bhattacharya S.
Melatonin and its anti-glioma functions: a comprehensive review.
Rev Neurosci. 2019 Jan 12. pii: /j/revneuro.ahead-of-print/revneuro-2018-0041/revneuro-2018-0041.xml. doi: 10.1515/revneuro-2018-0041. [Epub ahead of print]
Source | Full text | Similar articles



BRAIN STEM GLIOMAS




DIFFUSE INTRINSIC PONTINE GLIOMAS


.

Guida L, Roux FE, Massimino M, Marras CE, Sganzerla E, Giussani C.
Safety and efficacy of Endoscopic Third Ventriculostomy in Diffuse Intrinsic Pontine Glioma related hydrocephalus: a Systematic Review.
World Neurosurg. 2018 Dec 30. pii: S1878-8750(18)32919-X. doi: 10.1016/j.wneu.2018.12.096. [Epub ahead of print]
Source | Full text | Similar articles



HIGH-GRADE GLIOMAS


.

Mahmoudi K, Garvey KL, Bouras A, Cramer G, Stepp H, Jesu Raj JG, Bozec D, Busch TM, Hadjipanayis CG.
5-aminolevulinic acid photodynamic therapy for the treatment of high-grade gliomas.
J Neurooncol. 2019 Feb;141(3):595-607. doi: 10.1007/s11060-019-03103-4. Epub 2019 Jan 18.
Source | Full text | Similar articles



.

Philbrick BD, Adamson DC.
Early clinical trials of Toca 511 and Toca FC show a promising novel treatment for recurrent malignant glioma.
Expert Opin Investig Drugs. 2019 Mar;28(3):207-216. doi: 10.1080/13543784.2019.1572112.
Source | Full text | Similar articles



.

Prelaj A, Rebuzzi SE, Grassi M, Salvati M, D'Elia A, Buttarelli F, Ferrara C, Tomao S, Bianco V.
Non-conventional fotemustine schedule as second-line treatment in recurrent malignant gliomas: Survival across disease and treatment subgroup analysis and review of the literature.
Mol Clin Oncol. 2019 Jan;10(1):58-66. doi: 10.3892/mco.2018.1746. Epub 2018 Oct 16.
Source | Full text | Similar articles
Referring to: Addeo R et al, A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma.
J Neurooncol. 2011 May;102(3):417-24. doi: 10.1007/s11060-010-0329-z. Epub 2010 Aug 10. Dosage error in published abstract. Correction in:
J Neurooncol. 2011 May;102(3):425. Epub 2010 Sep 21. Source , Full text , Erratum



.

Young JS, Dayani F, Morshed RA, Okada H, Aghi MK.
Immunotherapy for High Grade Gliomas: A Clinical Update and Practical Considerations for Neurosurgeons.
World Neurosurg. 2019 Jan 21. pii: S1878-8750(19)30106-8. doi: 10.1016/j.wneu.2018.12.222. [Epub ahead of print]
Source | Full text | Similar articles



DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS



GLIOBLASTOMA


.

Abi-Aad KR, Turcotte EL, Welz ME, Krishna C, Mrugala MM, Porter AB, Vora SA, Bendok BR.
The Use of Recombinant Poliovirus for the Treatment of Recurrent Glioblastoma Multiforme.
World Neurosurg. 2019 Jan 23. pii: S1878-8750(19)30147-0. doi: 10.1016/j.wneu.2019.01.050. [Epub ahead of print]
Source | Full text | Similar articles



.

Ahmad F, Sun Q, Patel D, Stommel JM.
Cholesterol Metabolism: A Potential Therapeutic Target in Glioblastoma.
Cancers (Basel). 2019 Jan 26;11(2). pii: E146. doi: 10.3390/cancers11020146.
Source | Full text | Similar articles



.

Buchmann N, Gempt J.
In Reply to Letter to the Editor Regarding "Can Early O-(2-18FFluoroethyl)-l-Tyrosine Positron Emission Tomography After the Resection of a Glioblastoma Predict the Location of Later Tumor Recurrence?"
World Neurosurg. 2019 Jan 17. pii: S1878-8750(18)32841-9. doi: 10.1016/j.wneu.2018.12.019. [Epub ahead of print]
Source | Full text | Similar articles
Referring to: Fang X et al, Letter to the Editor Regarding “Can Early Postoperative O-(2-18FFluoroethyl)-l-Tyrosine Positron Emission Tomography After Resection of Glioblastoma Predict the Location of Later Tumor Recurrence?” World Neurosurg. 2019 Feb 26. pii: S1878875018323477. doi: 10.1016/j.wneu.2018.10.050. [Epub ahead of print] Source , Full text
In turn referring to: Buchmann N et al, Can Early Postoperative O-(2-
18FFluoroethyl)-l-Tyrosine Positron Emission Tomography After Resection of Glioblastoma Predict the Location of Later Tumor Recurrence? World Neurosurg. 2019 Jan;121:e467-e474. doi: 10.1016/j.wneu.2018.09.139. Epub 2018 Sep 27. Source , Full text



.

Ciechomska IA.
The role of autophagy in cancer - characterization of crosstalk between apoptosis and autophagy; autophagy as a new therapeutic strategy in glioblastoma.
Postepy Biochem. 2018 Oct 15;64(2):119-128. doi: 10.18388/pb.2018_121.
Source | Full text | Similar articles



.

Fang X, Kong W, Yu Z, Qiu J, Duan H.
Letter to the Editor Regarding “Can Early Postoperative O-(2-18FFluoroethyl)-l-Tyrosine Positron Emission Tomography After Resection of Glioblastoma Predict the Location of Later Tumor Recurrence?”
World Neurosurg. 2019 Feb 26. pii: S1878875018323477. doi: 10.1016/j.wneu.2018.10.050. [Epub ahead of print]
Source | Full text | Similar articles
Referring to: Buchmann N et al, Can Early Postoperative O-(2-18FFluoroethyl)-l-Tyrosine Positron Emission Tomography After Resection of Glioblastoma Predict the Location of Later Tumor Recurrence? World Neurosurg. 2019 Jan;121:e467-e474. doi: 10.1016/j.wneu.2018.09.139. Epub 2018 Sep 27. Source , Full text



.

Geraldo LHM, Garcia C, da Fonseca ACC, Dubois LGF, de Sampaio E Spohr TCL, Matias D, de Camargo Magalhães ES, do Amaral RF, da Rosa BG, Grimaldi I, Leser FS, Janeiro JM, Macharia L, Wanjiru C, Pereira CM, Moura-Neto V, Freitas C, Lima FRS.
Glioblastoma Therapy in the Age of Molecular Medicine.
Trends Cancer. 2019 Jan;5(1):46-65. doi: 10.1016/j.trecan.2018.11.002. Epub 2018 Dec 7.
Source | Full text | Similar articles



.

Khansur E, Shah AH, Lacy K, Komotar RJ.
Novel Immunotherapeutics for Treatment of Glioblastoma: The Last Decade of Research.
Cancer Invest. 2019 Jan 11:1-7. doi: 10.1080/07357907.2018.1479414. [Epub ahead of print]
Source | Full text | Similar articles



.

Tomicic MT, Christmann M.
Targeting anticancer drug-induced senescence in glioblastoma therapy.
Oncotarget. 2018 Dec 25;9(101):37466-37467. doi: 10.18632/oncotarget.26502. eCollection 2018 Dec 25.
Source | Full text | Similar articles
Referring to: Aasland D et al, Temozolomide Induces Senescence and Repression of DNA Repair Pathways in Glioblastoma Cells via Activation of ATR-CHK1, p21, and NF-κB. Cancer Res. 2019 Jan 1;79(1):99-113. doi: 10.1158/0008-5472.CAN-18-1733. Epub 2018 Oct 25. Source , Full text



.

van Schaijik B, Wickremesekera AC, Mantamadiotis T, Kaye AH, Tan ST, Stylli SS, Itinteang T.
Circulating tumor stem cells and glioblastoma: A review.
J Clin Neurosci. 2019 Mar;61:5-9. doi: 10.1016/j.jocn.2018.12.019. Epub 2019 Jan 6.
Source | Full text | Similar articles



.

Wong ET, Swanson KD.
Dexamethasone-Friend or Foe for Patients With Glioblastoma?
JAMA Neurol. 2019 Jan 22. doi: 10.1001/jamaneurol.2018.4530. [Epub ahead of print]
Source | Full text | Similar articles



.

Zikou A, Sioka C, Alexiou GA, Fotopoulos A, Voulgaris S, Argyropoulou MI.
Radiation Necrosis, Pseudoprogression, Pseudoresponse, and Tumor Recurrence: Imaging Challenges for the Evaluation of Treated Gliomas.
Contrast Media Mol Imaging. 2018 Dec 2;2018:6828396. doi: 10.1155/2018/6828396. eCollection 2018.
Source | Full text | Similar articles



OLIGODENDROGLIOMAS


.

Laghari AA, Khalid MU, Qadeer N, Shamim MS.
Prognostic value of 1p/19q chromosomal codeletion in patients with oligodendroglioma. [With a review of the literature].
J Pak Med Assoc. 2019 Jan;69(1):132-134.
Source | Full text | Similar articles



OTHER ASTROCYTIC TUMORS



PILOCYTIC ASTROCYTOMA


.

Konar SK, Shukla D, Nandeesh BN, Prabhuraj AR, Devi BI.
Surgical Management and Outcome of a Bilateral Thalamic Pilocytic Astrocytoma: Case Report and Review of the Literature.
Pediatr Neurosurg. 2019 Jan 24:1-4. doi: 10.1159/000495990. [Epub ahead of print]
Source | Full text | Similar articles



OTHER GLIOMAS



CHORDOID GLIOMA OF THE THIRD VENTRICLE


.

Danilowicz K, Abbati SG, Sosa S, Witis FL, Sevlever G.
Suprasellar chordoid glioma: a report of two cases. [With a review of the literature].
Arch Endocrinol Metab. 2018 Dec;62(6):648-654. doi: 10.20945/2359-3997000000092.
Source | Full text | Similar articles



EMBRYONAL TUMORS



MEDULLOBLASTOMA


.

Padovani L, Horan G, Ajithkumar T.
Radiotherapy Advances in Paediatric Medulloblastoma Treatment.
Clin Oncol (R Coll Radiol). 2019 Mar;31(3):171-181. doi: 10.1016/j.clon.2019.01.001. Epub 2019 Jan 14.
Source | Full text | Similar articles



bottom